Masanori　Itou

Last Updated :2019/02/01

Affiliations, Positions
Graduate School of Biomedical & Health Sciences (Biomedical Sciences Major), Associate Professor

Basic Information

Major Professional Backgrounds

  • 1994/04/01, 1996/05/31, Saiseikai Kure Hospital
  • 1996/06/01, 2000/05/31, Medical Corporation JR Hiroshima Hospital
  • 2000/06/01, 2002/09/30, Hiroshima University, Health Service Center, Research Associate
  • 2002/10/01, 2007/06/30, Hiroshima University Hospital, Research Associate
  • 2007/07/01, 2016/03/31, Hiroshima University, Hospital, Lecturer
  • 2016/04/01, Hiroshima University, Institute of Biomedical & Health Sciences, Associate Professor

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Gastroenterology

Research Keywords

  • gastric cancer
  • gastritis

Educational Activity

Course in Charge

  1. 2018, Undergraduate Education, Intensive, Clinical diagnosis and treatment I
  2. 2018, Undergraduate Education, Intensive, Symptomatology, Diagnosis and Treatment
  3. 2018, Undergraduate Education, Intensive,
  4. 2018, Undergraduate Education, Intensive, Clinical Clerkship (Advanced Course)
  5. 2018, Undergraduate Education, First Semester, Internal Medicine I
  6. 2018, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Gastroenterology and Metabolism
  7. 2018, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Gastroenterology and Metabolism
  8. 2018, Graduate Education (Doctoral Program) , First Semester, Advanced research on Gastroenterology and Metabolism
  9. 2018, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Gastroenterology and Metabolism

Research Activities

Academic Papers

  1. Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development, JOURNAL OF MEDICAL MICROBIOLOGY, 59(12), 1484-1489, 201012
    Link to Paper Search Results by DOI
  2. Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese, HELICOBACTER, 16(6), 415-419, 201112
    Link to Paper Search Results by DOI
  3. Evaluation of Individual Risk in Nonvariceal Gastrointestinal Bleeding Patients with NSAID Administration: A Multicenter Study in Japan, DIGESTION, 86(3), 187-193, 2012
    Link to Paper Search Results by DOI
  4. Gastric Cancer Development after Helicobacter pylori Eradication Therapy: A New Form of Gastric Neoplasia, DIGESTION, 85(1), 61-67, 2012
    Link to Paper Search Results by DOI
  5. Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27(3), 598-602, 201203
    Link to Paper Search Results by DOI
  6. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial, DISEASES OF THE ESOPHAGUS, 25(5), 373-380, 201207
    Link to Paper Search Results by DOI
  7. High Expression of Gastrin Receptor Protein in Injured Mucosa of Helicobacter pylori-Positive Gastritis, DIGESTIVE DISEASES AND SCIENCES, 58(3), 634-640, 201303
    Link to Paper Search Results by DOI
  8. The effect of Helicobacter pylori eradication therapy on gastric ulcer healing after endoscopic mucosal resection, J Clin Gastroenterol, 40(4), 293-296, 20060401
  9. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: Association with Helicobacter pylori infection, Int. J. Molecular Med., 5: 185-190, 20000101
  10. Changing pattern of gastric cancer in Japan, 2nd International Gastric Cancer Congress= Munich, 19970612
  11. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with nalysis of p53 and K-ras alteration and microsatellite instability, Int J Oncol, 18, 1207-1212, 20010401
  12. Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication, Oncol.Rep., 8, 293-297, 20010401
  13. Reduction in the incidence of Helicobacter pylori-associated carcinoma in Japanese young adalts, Oncol.Rep., 8, 633-636, 20010401
  14. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer desease.;, Aliment Pharmacol Ther, 21, 99-104, 20050101
  15. Corrrespondence, Dig Liver Dis, 37, 982, 20051201
  16. Surface structure of antral gastric mucosa represents the status of histologic gastritis: fundamental evidence for the evaluation of antral gastritis by magnifying endoscopy., J Gastroenterol Hepatol, 21, 837-841, 20060501
  17. Biomarkers in patients with gastic inflammation: a systematic review., Digestion, 72, 164-180, 20050401
  18. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis., World J Gastroenterol, 12(1), 10-16, 20060101
  19. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma, Oncol Rep, 11, 315-319, 20040401
  20. Chromosomal and microsatellite instability in sporadic gastric cancer, J Gastroenterol Hepatol, 19, 756-760, 20040501
  21. Chronic gastritis with expression of inducible nitric oxide synthase is associated with high expression of interleukin-6 and hypergastrinaemia, Aliment Pharmacol Ther, 19, 1309-1314, 20040401
  22. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan, Aliment Pharmacol Ther, 21, 1121-1126, 20050501
  23. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma, Int J Oncol, 24, 539-547, 20040201
  24. Clinicopathologic and endoscopic features of colorectal serrated adenoma:differences between polypoid and superficial types, Gastrointest Endosc, 59(2), 213-219, 20040201
  25. Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma, J Clin Gastroenterol, 37(5), 381-386, 20040501
  26. Development of a novel method to detect Helicobacter pylori cagA genotype from paraffin-embedded materials: comparison between patients with duodenal ulcer and gastric cancer in young Japanese, Digestion, 73, 47-53, 20060401
  27. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease, Aliment Pharmacol Ther, 21, 99-104, 20050601
  28. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients, Dig Liver Dis, 37, 39-43, 20050101
  29. Frequent loss of heterozygosity on chromosome 10p14-p15 in esophageal dysplasia and squamous cell carcinoma, Oncol Rep, 12, 333-337, 20040401
  30. Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia, Dig Dis Sci, 51, 1582-1588, 20060901
  31. Loss of heterozygosity on chromosome 10p14-p15 in colorectal carcinoma, Pathobiology, 72, 220-224, 20050901
  32. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer, Dis Colon Rectum, 50(1), 13-21, 20060101
  33. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation, Inflamm Bowel Dis, 10(6), 737-744, 20040601
  34. Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum, Dig Liver Dis, 36, 286-291, 20040401
  35. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia, J Gastroenterol Hepatol, 22, 304-310, 20070301
  36. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up, Aliment Pharmacol Ther, 21, 559-566, 20050301
  37. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach, Oncology, 66(8), 379-387, 20040401
  38. Relationship between histopathological features and type V pit pattern determined by magnifying videocolonoscopy in early colorectal carcinoma, Dig Endos, 17, 117-122, 20050401
  39. Immune response to cagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura, Helicobacter, 12, 36-42, 20070201
  40. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori:preliminary report, J Gastroenterol Hepatol, 22, 571-576, 20070401
  41. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan, Aliment Pharmacol Ther, 26, 677-679, 20070701
  42. Helicobacter pylori-associated gastritisis related to babA2expression without heterogeneity of the 3' region of the cagA genotype in Gastric Biopsy Specimens, Pathobiology, 74(5), 1-7, 20070401
  43. Treatment of functional dyspepsia with serotonin agonists: A meta-analysis of randomized controlled trials, J Gastroenterol Hepatol, 22, 1566-1570, 20071001
  44. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study, Scand J Gastroenterol, 42, 760-764, 20070601
  45. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia, Jpn J Clin Oncol, 37, 365-369, 20071213
  46. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy., Oncogene, 26(30), 4383-4393, 20070701
  47. Serum concentration of Reg IV in patients with colorectal cancer: Overexpression and high Reg IV serum level is associated with liver metastasis., Oncology, IN PRESS, 20071201
  48. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography, J Gastroenterol, 43, 332-227, 20081201
  49. Role of the gastrin-gastrin receptor system in the expansive growth of human gastric neoplasms, Digestion, 78, 163-170, 20081201
  50. Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study, Dig Dis Sci, 58, 1818-1823, 20091001
  51. Presence of poorly differentiated component correlated with submucosal invasion in the early diffuse-type gastric cancer., Hepato-Gastroenterology, 55, 2264-2268, 20091001
  52. A case of gastric adenocarcinoma arising from a fundic gland polyp, Clin J Gastroenterol, 2, 279-283, 20091001
  53. Ecabet sodium induces neuronal nitric oxide synthase-derived nitric oxide synthesis and gastric adaptive relaxation in the human stomach, J Gastroenterol, 44, 1118-1124, 20091101
  54. Infliximab treatment for Crohn's disease in a patient with IgA nephropathy, Clin J Gastroenterol, 2, 380-383, 20091201
  55. Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index., Pathol Res Pract., 207(6), 354-358, 20110601
  56. A Water-soluble extract from culture medium of ganoderma lucidum mycelia suppresses the development of colorectal adenoma, Hiroshima J Med Sci, 59(1), 1月6日, 20100101
  57. Cheilitis granulomatosa as an early manifestation of Crohn's disease, Clin J Gastroenterol, 2, 190-193, 20090501
  58. Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients, J Gastroenterol, 44(5), 405-411, 20090501
  59. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review, J Gastroenterol, 44(5), 365-371, 20090501
  60. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior Helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study, Hepatogastroenterology, 56(91-92), 624-628, 20090601
  61. Ecabet sodium induces neuronal nitric oxide synthase-derived nitric oxide synthesis and gastric adaptive relaxation in the human stomach, J Gastroenterol, 44(8), 1118-1124, 20090801
  62. Infliximab treatment for Crohn's disease in a patient with IgA nephropathy, Clin J Gastroenterol, 2, 380-383, 20091001
  63. Plaunotol induces a comparative increase of acidic mucin fraction in gastric juice, Hepatogastroenterology, 58(106), 663-668, 20110301
  64. Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis., Dig Dis Sci., 47(4), 862-867, 20020401
  65. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis., Int J Cancer., 100(3), 304-308, 20020701
  66. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis., Aliment Pharmacol Ther., 16(8), 1449-1456, 20020801
  67. Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gastric carcinogenesis., Dig Dis Sci., 47(5), 1080-1085, 20020501
  68. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis., Scand J Gastroenterol., 37(3), 287-293, 20020301
  69. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients., Eur J Gastroenterol Hepatol., 14(2), 123-127, 20020201
  70. Single administration of ecabet sodium diminishes the level of delta-13CO2 in urea breath test., J Gastroenterol., 37(8), 674-675, 20020801
  71. Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication., Oncol Rep, 8(2), 293-7, 20010401
  72. c-myc gene mutation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma, Oncol Rep, 8(2), 289-92, 20010401
  73. Reduction in the incidence of Helicobacter pylori-associated carcinoma in Japanese young adults, Oncol Rep, 8(3), 633-6, 20010501
  74. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability, Int J Oncol, 18(6), 1207-12, 20010601
  75. Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients, Scand J Gastroenterol, 35(3), 255-259, 20000301
  76. Enhanced expression of inducible Nitric Oxide Synthase and Nitrotyrosine in gastric mucosa of gastric cancer patients, Clin Cancer Res, 5(6), 1411-5., 19990601
  77. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas., Jpn J Cancer Res, 83(1), 86-92, 19920101
  78. New prognostic factors in human gastric carcinomas, 19(1), 26-33, 20010101
  79. monoclonal antibody capable of detecting new differentiation antigen of the stomach, Int J Cancer, 50(4), 523-7, 19920201
  80. Expression of several growth factors and their receptor genes in human colon carcinomas, Virchows Arch B Cell Pathol Incl Mol Pathol., 59(3), 173-178, 19900401
  81. Minute carcinoid arising in gastric tubular adenoma, Histopathology., 15(1), 96-99, 19890701
  82. Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1, Jpn J Cancer Res, 80(8), 743-746, 19890801
  83. Cytogenetical analysis of the human gastric carcinoma cell line TMK-1, Hiroshima J Med Sci, 38(3), 121-124, 19890901
  84. Reduced tumorigenicity and cell motility of a gastric-carcinoma cell-line by introduction of wild-type p53 gene., Int J Oncol, 3(2), 265-71, 19930801
  85. Papillary adenoma of the stomach. Pathologic and immunohistochemical study., Arch Pathol Lab Med., 113(９), 1030-4, 19890901
  86. Expression of several growth factors and their receptor genes in human colon carcinomas., Virchows Arch B Cell Pathol Incl Mol Pathol, 59(3), 173-8., 19900101
  87. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm, Helicobacter, 19(1), 1-8, 20140201
  88. Reduction in the incidence of Helicobacter pylori-associated carcinoma in Japanese young adults, ONCOLOGY REPORTS, 8(3), 633-636, 2001
    Link to Paper Search Results by DOI
  89. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: Evaluation in a country of high prevalence of atrophic gastritis, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 37(3), 287-293, 200203
    Link to Paper Search Results by DOI
  90. Serological comparison of serum pepsinogen and antiparietal cell antibody levels between Japanese and German patients, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 14(2), 123-127, 200202
    Link to Paper Search Results by DOI
  91. Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis, DIGESTIVE DISEASES AND SCIENCES, 47(4), 862-867, 200204
    Link to Paper Search Results by DOI
  92. Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gastric carcinogenesis, DIGESTIVE DISEASES AND SCIENCES, 47(5), 1080-1085, 200205
    Link to Paper Search Results by DOI
  93. p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis, INTERNATIONAL JOURNAL OF CANCER, 100(3), 304-308, 20020720
    Link to Paper Search Results by DOI
  94. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer, DIGESTIVE DISEASES AND SCIENCES, 48(4), 644-651, 200304
    Link to Paper Search Results by DOI
  95. Expression of hypoxia-inducible factor-l alpha is associated with tumor vascularization in human colorectal carcinoma, INTERNATIONAL JOURNAL OF CANCER, 105(2), 176-181, 20030610
    Link to Paper Search Results by DOI
  96. Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori, JOURNAL OF GASTROENTEROLOGY, 38(4), 371-375, 200304
    Link to Paper Search Results by DOI
  97. Somatic mutation of mitochondrial DNA in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 12(2), 169-174, 200308
    Link to Paper Search Results by DOI
  98. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 18, 153-159, 200307
    Link to Paper Search Results by DOI
  99. Clinical significance of Fhit expression in development of colorectal carcinoma of various macroscopic types, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 12(4), 437-442, 200310
    Link to Paper Search Results by DOI
  100. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 311(4), 809-814, 20031128
    Link to Paper Search Results by DOI
  101. Involvement of proinflammatory cytokines IL-1 beta and IL-6 in progression of human gastric carcinoma, ANTICANCER RESEARCH, 25(2A), 709-713, 2005
    Link to Paper Search Results by DOI
  102. Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum, DIGESTIVE AND LIVER DISEASE, 36(4), 286-291, 200404
    Link to Paper Search Results by DOI
  103. Chronic gastritis with expression of inducible nitric oxide synthase is associated with high expression of interleukin-6 and hypergastrinaemia, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 19(12), 1309-1314, 20040615
    Link to Paper Search Results by DOI
  104. A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: A multicenter study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 20(8), 1241-1245, 200508
    Link to Paper Search Results by DOI
  105. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation, INFLAMMATORY BOWEL DISEASES, 10(6), 737-744, 200411
    Link to Paper Search Results by DOI
  106. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients, DIGESTIVE AND LIVER DISEASE, 37(1), 39-43, 200501
    Link to Paper Search Results by DOI
  107. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 21(5), 559-566, 20050301
    Link to Paper Search Results by DOI
  108. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 21(9), 1121-1126, 20050501
    Link to Paper Search Results by DOI
  109. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 21, 99-104, 200506
    Link to Paper Search Results by DOI
  110. Cardiac glands hyperplastic polyp of the stomach, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 20(9), 1461-1463, 200509
    Link to Paper Search Results by DOI
  111. Biomarkers in patients with gastric inflammation: A systematic review, DIGESTION, 72(2-3), 164-180, 2005
    Link to Paper Search Results by DOI
  112. Evaluation of an ELISA for detection of anti-parietal cell antibody, HEPATO-GASTROENTEROLOGY, 53(67), 11-14, 2006
    Link to Paper Search Results by DOI
  113. The effect of Helicobacter pylori eradication therapy on gastric ulcer healing after endoscopic mucosal resection, JOURNAL OF CLINICAL GASTROENTEROLOGY, 40(4), 293-296, 200604
    Link to Paper Search Results by DOI
  114. Development of a novel method to detect Helicobacter pylori cagA genotype from paraffin-embedded materials: Comparison between patients with duodenal ulcer and gastric cancer in young Japanese, DIGESTION, 73(1), 47-53, 2006
    Link to Paper Search Results by DOI
  115. Surface structure of antral gastric mucosa represents the status of histologic gastritis: Fundamental evidence for the evaluation of antral gastritis by magnifying endoscopy, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21(5), 837-841, 200605
    Link to Paper Search Results by DOI
  116. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma, DIGESTIVE AND LIVER DISEASE, 38(5), 303-307, 200605
    Link to Paper Search Results by DOI
  117. A case of Crohn's disease with hydronephrosis caused by ureteropelvic junction obstruction, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 18(9), 1015-1018, 200609
    Link to Paper Search Results by DOI
  118. Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia, DIGESTIVE DISEASES AND SCIENCES, 51(9), 1582-1588, 200609
    Link to Paper Search Results by DOI
  119. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(1), 69-77, 20070701
    Link to Paper Search Results by DOI
  120. Serum pepsinogen levels in the Japanese population: Prospective study of 9 years of follow-up, HEPATO-GASTROENTEROLOGY, 54(78), 1887-1890, 200709
    Link to Paper Search Results by DOI
  121. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography, JOURNAL OF GASTROENTEROLOGY, 43(5), 332-337, 2008
    Link to Paper Search Results by DOI
  122. Evaluation of gastric cancer risk using topography of histological gastritis: A large-scaled cross-sectional study, DIGESTIVE DISEASES AND SCIENCES, 53(7), 1818-1823, 200807
    Link to Paper Search Results by DOI
  123. Role of the Gastrin-Gastrin Receptor System in the Expansive Growth of Human Gastric Neoplasms, DIGESTION, 78(2-3), 163-170, 2008
    Link to Paper Search Results by DOI
  124. Presence of Poorly Differentiated Component Correlated with Submucosal Invasion in the Early Diffuse-type Gastric Cancer, HEPATO-GASTROENTEROLOGY, 55(88), 2264-2268, 2008
    Link to Paper Search Results by DOI
  125. Relationship between Helicobacter pylori Tyrosine-Phosphorylated CagA-Related Markers and the Development of Diffuse-Type Gastric Cancers: A Case-Control Study, DIGESTION, 82(1), 10-17, 2010
    Link to Paper Search Results by DOI
  126. Plaunotol Induces a Comparative Increase of Acidic Mucin Fraction in Gastric Juice, HEPATO-GASTROENTEROLOGY, 58(106), 663-668, 2011
    Link to Paper Search Results by DOI
  127. Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index, PATHOLOGY RESEARCH AND PRACTICE, 207(6), 354-358, 2011
    Link to Paper Search Results by DOI
  128. Helicobacter pylori cagA polymorphism and gastric inflammation: An international comparison between Japanese and Brazilian patients, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 46(9), 1051-1056, 201109
    Link to Paper Search Results by DOI
  129. Bile Acid Promotes Intestinal Metaplasia and Gastric Carcinogenesis, CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 21(11), 2101-2107, 201211
    Link to Paper Search Results by DOI
  130. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27(5), 899-906, 201205
    Link to Paper Search Results by DOI
  131. Histology of symptomatic gastroesophageal reflux disease: Is it predictive of response to proton pump inhibitors?, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(3), 479-487, 201303
    Link to Paper Search Results by DOI
  132. Changes in endoscopic findings of gastritis after cure of H.pylori infection: Multicenter prospective trial, DIGESTIVE ENDOSCOPY, 25(3), 264-273, 201305
    Link to Paper Search Results by DOI
  133. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: A multicenter study of 2283 cases, DIGESTIVE ENDOSCOPY, 25(5), 519-525, 201309
    Link to Paper Search Results by DOI
  134. Characteristics of Metachronous Gastric Tumors after Endoscopic Submucosal Dissection for Gastric Intraepithelial Neoplasms, GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014
    Link to Paper Search Results by DOI
  135. Management and clinical outcomes of type I gastric carcinoid patients: Retrospective, multicenter study in Japan, DIGESTIVE ENDOSCOPY, 26(3), 377-384, 201405
    Link to Paper Search Results by DOI
  136. Characteristic Epithelium with Low-Grade Atypia Appears on the Surface of Gastric Cancer after Successful Helicobacter pylori Eradication Therapy, HELICOBACTER, 19(4), 289-295, 201408
    Link to Paper Search Results by DOI
  137. Advanced Method for Evaluation of Gastric Cancer Risk By Serum Markers: Determination of True Low-Risk Subjects for Gastric Neoplasm, HELICOBACTER, 19(1), 1-8, 201402
    Link to Paper Search Results by DOI
  138. Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study, BIOMED RESEARCH INTERNATIONAL, 2015
    Link to Paper Search Results by DOI
  139. Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40Years in Japan, HELICOBACTER, 20(3), 192-198, 201506
    Link to Paper Search Results by DOI
  140. Interobserver and intraobserver agreement for gastric mucosa atrophy, BMC GASTROENTEROLOGY, 15, 20150804
    Link to Paper Search Results by DOI
  141. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(10), 1473-1477, 201510
    Link to Paper Search Results by DOI
  142. Time trends in Helicobacter pylori Infection and atrophic gastritis over 40 years in Japan, Helicobacter, 12193, 2015
  143. nterobserver and intraobserver agreement for gastric mucosa atrophy, BMC Gastroenterol, 15, 95, 2015
  144. Diagnosis of helicobacter pylori-induced gastritis by serum pepsinogen levels　, J Gastroenterol Hepatol, 30(10), 1473-1477, 2015
  145. ate of unintended Helicobacter pylori eradication in the Vietnamese, Helicobacter, 20(2), 156-157, 2015
  146. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study, Gut, 64(9), 1353-1367, 2015
  147. Helicobacter pylori陰性胃癌, 消化器の臨床, 18(2), 133-136, 2015
  148. 酸分泌抑制薬の歴史, 日本医事新報No4751, 4751, 20-23, 2015
  149. Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 52(8), 828-832, 2017
    Link to Paper Search Results by DOI
  150. Indications for Small-bowel Capsule Endoscopy in Patients with Chronic Abdominal Pain, INTERNAL MEDICINE, 56(12), 1453-1457, 2017
    Link to Paper Search Results by DOI
  151. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings, DIGESTION, 95(4), 314-318, 2017
    Link to Paper Search Results by DOI
  152. Reduced human α-defensin 6 in noninflamed jejunal tissue of patients with crohn's disease, Inflamm Bowel Dis, 22(5), 1119-1128, 2016
  153. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study, GASTRIC CANCER, 20(5), 764-771, 201709
    Link to Paper Search Results by DOI
  154. Clinical Significance of Reddish Depressed Lesions Observed in the Gastric Mucosa after Helicobacter pylori Eradication, DIGESTION, 98(1), 48-55, 2018
    Link to Paper Search Results by DOI

Publications such as books

  1. 2006/04, Molecular pathologic application as a predictor of lymph node metastasis in submucosal colorectal carcinoma:implication of immunohistochemical alterations at the deepest invasive margin , 2006, 04, 171
  2. 2015, 5 Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study, 5 Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study, 2015
  3. 2015, Rate of unintended Helicobacter pylori eradication in the Vietnamese, Rate of unintended Helicobacter pylori eradication in the Vietnamese, Rate of unintended Helicobacter pylori eradication in the Vietnamese, Rate of unintended Helicobacter pylori eradication in the Vietnamese, 2015, Hiyama T, Quach DT, Le QD, Ho LX, Vu NH, Shimamoto F, Ito M, Tanaka S, Yoshihara M, Uemura N, Chayama K.
  4. 2015, Time trends in Helicobacter pylori Infection and atrophic gastritis over 40 years in Japan, Time trends in Helicobacter pylori Infection and atrophic gastritis over 40 years in Japan, Time trends in Helicobacter pylori Infection and atrophic gastritis over 40 years in Japan, Helicobacter, 2015, Kamada T, Haruma K, Ito M, Inoue K, Manabe N, Matsumoto H, Kusunoki H, Hata J, Yoshihara M, Sumii K, Akiyama T, Tanaka S, Shiotani A, David Y. Graham.

Invited Lecture, Oral Presentation, Poster Presentation

  1. he potential role of polysaccharides derived from Ganoderma lucidum fungus mycelia (designated as MAK) on ameliorating indomethacin-induced small intestinal injuries through GM-CSF, Nagai K, Ueno Y, Tanaka S, Sagami S, Nishiyama S, Shinagawa K, Oka S, Yoshida S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, Nagai K, Ueno Y, Tanaka S, Sagami S, Nishiyama S, Shinagawa K, Oka S, Yoshida S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, American Society for Gastrointestinal Endoscopy (ASGE) 2015, 2015/05/16, Without Invitation
  2. Delayed-release oral mesalazine and probiotics in maintaining of ulcerative colitis-a retrospective cohort study, Sagami S, Ueno Y, Tanaka S, Hayashi R, Nishiyama S, Nagai K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, Sagami S, Ueno Y, Tanaka S, Hayashi R, Nishiyama S, Nagai K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, The 3rd Annual Meeting of Asian Organization for Crohn's & Colitis (AOCC) 2015, 2015/06/18, Without Invitation
  3. Methionine-choline deficient diet relieves dextran sodium sulfate-induced colitis via maintenance of non type Ⅰ NKT cells, Sagami S, Ueno Y, Tanaka S, Nishiyama S, Hayashi R, Nagai K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K., Sagami S, Ueno Y, Tanaka S, Nishiyama S, Hayashi R, Nagai K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K., 2015/07/14, Without Invitation
  4. The potential role of polysaccharides derived from Ganoderma lucidum fungus mycelia (designated as MAK) on ameliorating indomethacin-induced small intestinal injuries through GM-CSF, Nagai K, Ueno Y, Tanaka S, Sagami S, Nishiyama S, Hayashi R, Shinagawa K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, Nagai K, Ueno Y, Tanaka S, Sagami S, Nishiyama S, Hayashi R, Shinagawa K, Oka S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Chayama K, The 17th International Cogress of Mucosal Immunology (ICMI2015), 2015/07/14, Without Invitation
  5. Present state of malpractice litigations pertaining to gastroenterological practice in Japan, Hiyama T, Oka S, Ueno Y, Ito M, Kitadai Y, Tanaka S, Yoshihara M, Chayama K, Hiyama T, Oka S, Ueno Y, Ito M, Kitadai Y, Tanaka S, Yoshihara M, Chayama K, Asian Pacific Digestive Week (APDW) 2015, 2015/12/03, Without Invitation
  6. Evaluation of gastric cancer risk by serum markers, Ito M, Yoshihara M, Tanaka S, Chayama K., Ito M, Yoshihara M, Tanaka S, Chayama K., The 22nd annual meeting of the Japanese Society for Helicobacter Research, 2016/06/24, Without Invitation, the Japanese Society for Helicobacter Research
  7. Choline deficiency influences murine colitis via balance of colonic type Ⅰ and Ⅱ NKT cells, Sagami S, Tanaka S, Ueno Y, Fujita A, Nomura M, Nishiyama S, Hayashi R, Urabe Y, Oka S, Ito M, Kitadai Y, Chayama K., Sagami S, Tanaka S, Ueno Y, Fujita A, Nomura M, Nishiyama S, Hayashi R, Urabe Y, Oka S, Ito M, Kitadai Y, Chayama K., American Society for Gastrointestinal Endoscopy (ASGE) 2016 (DDW), 2016/05/21, Without Invitation, American Society for Gastrointestinal Endoscopy
  8. Colonic Manifestations of Chronic Granulomatous Disease, Sagami S, Tanaka S, Ueno Y, Nagai K, Fujita A, Nishiyama S, Hayashi R, Oka S, Ito M, Kitadai Y, Miki M, Doi T, Mizoguchi Y, Kobayashi M, Chayama K., Sagami S, Tanaka S, Ueno Y, Nagai K, Fujita A, Nishiyama S, Hayashi R, Oka S, Ito M, Kitadai Y, Miki M, Doi T, Mizoguchi Y, Kobayashi M, Chayama K., American Society for Gastrointestinal Endoscopy (ASGE) 2016 (DDW), 2016/05/21, Without Invitation, American Society for Gastrointestinal Endoscopy
  9. Autoimmune gastritis in Japan: a study of 200 patients at multicenter study, Terao S, Furuta T, Kamada T, Maruyama Y, Syunto J, Aoki R, Ito M, Manabe N, Sato Y, Oho K, Inoue K, Shiotani A, Haruma K., Terao S, Furuta T, Kamada T, Maruyama Y, Syunto J, Aoki R, Ito M, Manabe N, Sato Y, Oho K, Inoue K, Shiotani A, Haruma K., American Society for Gastrointestinal Endoscopy (ASGE) 2017 (DDW), 2017/05/06, Without Invitation, American Society for Gastrointestinal Endoscopy

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research for Innovative Cancer Control, 2015/04/01, 2016/03/31
  2. KAKENHI, Identification of high-risk group for undifferentiated-type gastric cancer and its clinical application for eradication therapy, 2010, 2012
    Permalink
  3. 2006, 2007
  4. KAKENHI, 2016, 2018
  5. Practical Research for Innovative Cancer Control , 2016/04/01, 2017/03/31
  6. 2017, 2017

Social Activities

Other Social Contributions

  1. Scientific Exchange Meeting 2015 in Hiroshima, Certification of PPI safety, Scientific Exchange Meeting 2015 in Hiroshima, Scientific Exchange Meeting 2015 in Hiroshima, 2015/02/26, 2015/02/26
  2. Scientific Exchange Meeting 2015 in Nagoya/Hiroshima, Kyoto classification of gastritis, Scientific Exchange Meeting 2015 in Nagoya/Hiroshima, Scientific Exchange Meeting 2015 in Nagoya/Hiroshima, 2015/11/05, 2015/11/05

History as Peer Reviews of Academic Papers

  1. 2007, Journal of gastroenterology
  2. 2008, Journal of gastroenterology
  3. 2009, Journal of gastroenterology
  4. 2010, Journal of gastroenterology
  5. 2011, Journal of gastroenterology
  6. 2012, Journal of gastroenterology